90 related articles for article (PubMed ID: 28632300)
1. Chemobacterial Synthesis of a Sialyl-Tn Cyclopeptide Vaccine Candidate.
Richard E; Pifferi C; Fiore M; Samain E; Le Gouëllec A; Fort S; Renaudet O; Priem B
Chembiochem; 2017 Sep; 18(17):1730-1734. PubMed ID: 28632300
[TBL] [Abstract][Full Text] [Related]
2. Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen.
Marcos NT; Pinho S; Grandela C; Cruz A; Samyn-Petit B; Harduin-Lepers A; Almeida R; Silva F; Morais V; Costa J; Kihlberg J; Clausen H; Reis CA
Cancer Res; 2004 Oct; 64(19):7050-7. PubMed ID: 15466199
[TBL] [Abstract][Full Text] [Related]
3. Mucin-type O-glycosylation in Fasciola hepatica: characterisation of carcinoma-associated Tn and sialyl-Tn antigens and evaluation of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.
Freire T; Casaravilla C; Carmona C; Osinaga E
Int J Parasitol; 2003 Jan; 33(1):47-56. PubMed ID: 12547345
[TBL] [Abstract][Full Text] [Related]
4. Heterovalent Glycodendrimers as Epitope Carriers for Antitumor Synthetic Vaccines.
Pifferi C; Thomas B; Goyard D; Berthet N; Renaudet O
Chemistry; 2017 Nov; 23(64):16283-16296. PubMed ID: 28845889
[TBL] [Abstract][Full Text] [Related]
5. Efficient chemoenzymatic synthesis of sialyl Tn-antigens and derivatives.
Ding L; Yu H; Lau K; Li Y; Muthana S; Wang J; Chen X
Chem Commun (Camb); 2011 Aug; 47(30):8691-3. PubMed ID: 21725542
[TBL] [Abstract][Full Text] [Related]
6. Chemoenzymatic synthesis of sialylated glycopeptides derived from mucins and T-cell stimulating peptides.
George SK; Schwientek T; Holm B; Reis CA; Clausen H; Kihlberg J
J Am Chem Soc; 2001 Nov; 123(45):11117-25. PubMed ID: 11697954
[TBL] [Abstract][Full Text] [Related]
7. Large-scale production of the carbohydrate portion of the sialyl-Tn epitope, alpha-Neup5Ac-(2-->6)-D-GalpNAc, through bacterial coupling.
Endo T; Koizumi S; Tabata K; Kakita S; Ozaki A
Carbohydr Res; 2001 Feb; 330(4):439-43. PubMed ID: 11269395
[TBL] [Abstract][Full Text] [Related]
8. Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA.
Julien S; Krzewinski-Recchi MA; Harduin-Lepers A; Gouyer V; Huet G; Le Bourhis X; Delannoy P
Glycoconj J; 2001; 18(11-12):883-93. PubMed ID: 12820722
[TBL] [Abstract][Full Text] [Related]
9. Efficient synthesis of 6'-sialyllactose, 6,6'-disialyllactose, and 6'-KDO-lactose by metabolically engineered E. coli expressing a multifunctional sialyltransferase from the Photobacterium sp. JT-ISH-224.
Drouillard S; Mine T; Kajiwara H; Yamamoto T; Samain E
Carbohydr Res; 2010 Jul; 345(10):1394-9. PubMed ID: 20231015
[TBL] [Abstract][Full Text] [Related]
10. Stable expression of sialyl-Tn antigen in T47-D cells induces a decrease of cell adhesion and an increase of cell migration.
Julien S; Lagadec C; Krzewinski-Recchi MA; Courtand G; Le Bourhis X; Delannoy P
Breast Cancer Res Treat; 2005 Mar; 90(1):77-84. PubMed ID: 15770530
[TBL] [Abstract][Full Text] [Related]
11. A Photobacterium sp. α2-6-sialyltransferase (Psp2,6ST) mutant with an increased expression level and improved activities in sialylating Tn antigens.
Ding L; Zhao C; Qu J; Li Y; Sugiarto G; Yu H; Wang J; Chen X
Carbohydr Res; 2015 May; 408():127-33. PubMed ID: 25593075
[TBL] [Abstract][Full Text] [Related]
12. One-pot multi-enzyme (OPME) chemoenzymatic synthesis of sialyl-Tn-MUC1 and sialyl-T-MUC1 glycopeptides containing natural or non-natural sialic acid.
Malekan H; Fung G; Thon V; Khedri Z; Yu H; Qu J; Li Y; Ding L; Lam KS; Chen X
Bioorg Med Chem; 2013 Aug; 21(16):4778-85. PubMed ID: 23535562
[TBL] [Abstract][Full Text] [Related]
13. Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines.
Grigalevicius S; Chierici S; Renaudet O; Lo-Man R; Dériaud E; Leclerc C; Dumy P
Bioconjug Chem; 2005; 16(5):1149-59. PubMed ID: 16173792
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies against the Tn-specific isolectin B4 from Vicia villosa seeds: characterization of the epitope of the blocking antibody VV34.
Medeiros A; Berois N; Balter H; Robles A; Perez-Payá E; Gimenez A; Calvete JJ; Osinaga E
Hybrid Hybridomics; 2004 Feb; 23(1):39-44. PubMed ID: 15000847
[TBL] [Abstract][Full Text] [Related]
15. Syntheses and Immunological Evaluation of Self-Adjuvanting Clustered N-Acetyl and N-Propionyl Sialyl-Tn Combined with a T-helper Cell Epitope as Antitumor Vaccine Candidates.
Chang TC; Manabe Y; Fujimoto Y; Ohshima S; Kametani Y; Kabayama K; Nimura Y; Lin CC; Fukase K
Angew Chem Int Ed Engl; 2018 Jul; 57(27):8219-8224. PubMed ID: 29768704
[TBL] [Abstract][Full Text] [Related]
16. Synthetic carbohydrate vaccines: synthesis and immunogenicity of Tn antigen conjugates.
Toyokuni T; Hakomori S; Singhal AK
Bioorg Med Chem; 1994 Nov; 2(11):1119-32. PubMed ID: 7757411
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of a single-molecule L-rhamnose-containing three-component vaccine and evaluation of antigenicity in the presence of anti-L-rhamnose antibodies.
Sarkar S; Lombardo SA; Herner DN; Talan RS; Wall KA; Sucheck SJ
J Am Chem Soc; 2010 Dec; 132(48):17236-46. PubMed ID: 21080675
[TBL] [Abstract][Full Text] [Related]
18. The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity.
Laubreton D; Bay S; Sedlik C; Artaud C; Ganneau C; Dériaud E; Viel S; Puaux AL; Amigorena S; Gérard C; Lo-Man R; Leclerc C
Cancer Immunol Immunother; 2016 Mar; 65(3):315-25. PubMed ID: 26847142
[TBL] [Abstract][Full Text] [Related]
19. Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry.
Cai H; Huang ZH; Shi L; Zhao YF; Kunz H; Li YM
Chemistry; 2011 May; 17(23):6396-406. PubMed ID: 21538615
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Tn and sialyl Tn antigen-lipid A analog conjugates for synthetic vaccines.
Miyajima K; Nekado T; Ikeda K; Achiwa K
Chem Pharm Bull (Tokyo); 1997 Sep; 45(9):1544-6. PubMed ID: 9332007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
